Statins in renal disease: ezetimibe and fibric acid drugs.

Female, 58 years of age. On a daily GLP-1 agonist, SGLT-2, metformin, not reaching goal. Started long-acting insulin, using insulin pen. Some improvements, but post prandials still elevated.

In this week's Homerun Slides, approaches to intensifying therapy in patients who are using basal insulin but are not yet at goal.

This week our Home Run Slides lay out a roadmap for insulin intensification, and the use of GLP-1 analogs and DPP4-I with insulin. If you follow the path your patients can safely intensify therapy with a greatly reduced risk of hypoglycemia. You can learn even more about all the different …

Dr. Paresh Dandona, Professor of Medicine and Chief of the Division of Endocrinology, Diabetes and Metabolism at the University of Buffalo, The State University of New York, continues his discussion with Associate Medical Editor Joy Pape at the 2015 ADA Sessions in Boston. This week, he shares his thoughts on the greatest advancements in diabetes care.